Table 2. NOS risk of bias scale for included cohort studies.
Studies | Selection |
Outcome |
|||||||
Representativeness of the exposed cohort | Selection of the non-exposed cohort | Ascertainment of exposure | Outcome of interest not present at start of study | Comparability | Assessment of outcome | Adequacy of duration of follow-up | Adequacy of completeness of follow-up | Total score (0–9) | |
Priori SG, et al.[7] | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 5 |
Brugada J, et al.[6] | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 6 |
Benito B, et al.[28] | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 6 |
Delise P, et al.[23] | 1 | 0 | 1 | 1 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 8 |
Probst V, et al.[25] | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 6 |
Nishii N, et al.[22] | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 6 |
Daoulah A, et al.[21] | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 5 |
Hiraoka M, et al.[20] | 1 | 0 | 1 | 1 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 8 |
Son MK, et al.[19] | 1 | 0 | 1 | 0 | 1 (gender) | 1 | 1 | 1 | 6 |
Tokioka K, et al.[18] | 1 | 0 | 1 | 0 | 1 (family history of SCD) | 1 | 1 | 1 | 6 |
Conte G, et al.[16] | 1 | 0 | 1 | 1 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 8 |
Dores H, et al.[15] | 1 | 0 | 1 | 0 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 7 |
Okamura H, et al.[17] | 1 | 0 | 1 | 0 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 7 |
Andorin A, et al.[13] | 1 | 0 | 1 | 1 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 8 |
Casado-Arroyo R, et al.[11] | 1 | 0 | 1 | 1 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 8 |
Kawazoe H, et al.[12] | 1 | 0 | 1 | 0 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 7 |
Rivard L, et al.[10] | 1 | 0 | 1 | 1 | 1 (gender) | 1 | 1 | 1 | 7 |
Kitamura T, et al.[8] | 1 | 0 | 1 | 0 | 2 (gender, family history of SCD) | 1 | 1 | 1 | 7 |
Sieira, et al.[9] | 1 | 0 | 1 | 1 | 1 (gender) | 1 | 1 | 1 | 7 |
NOS: Newcastle-Ottawa scale; SCD: sudden cardiac death.